European Archives - European Medical Journal

HIV virus in the blood

NHS Rolls Out Trailblazing Treatment for Drug Resistant HIV

A new ‘trailblazing’ HIV treatment will offer hope to people with rare, drug-resistant HIV across England.

Woman gets waist measured by nurse

Weight Loss Cuts Endometrial Cancer Surgery Complications

A 28-day low-calorie diet before surgery halved complication rates in endometrial cancer patients.

Encephalitis Linked to Long-Term Dementia Risk, Study Finds

A large US study has found that encephalitis is linked to a significantly higher long-term risk of dementia, especially non-infectious and viral cases.

Omental Endothelial Cells Drive Ovarian Cancer Growth

New findings challenge the role of mature adipocytes in ovarian cancer growth and highlight omental endothelial FABP4 as a potential driver.

Young child blowing her nose into a tissue

NICE widens access to allergy drugs for young children

Children as young as five could soon have access to allergy immunotherapy tablets on the NHS.

Maternal Mental Health, Trauma, and Family Separation

In this series, host Saranya Ravindran explores the intersection of maternal mental health, trauma, domestic abuse, safeguarding, and…

bioinformatics

Machine Learning Identifies CHAF1A In Burkitt Lymphoma

An integrated transcriptomic and machine-learning analysis identified CHAF1A as a candidate biomarker and potential therapeutic target in Burkitt lymphoma.

Child with red rash on chest being examined by doctor who wears blue latex gloves

Direct Antibiotic Allergy Testing De-labels Most Children

Direct testing safely removed beta-lactam allergy labels in most children with mild reactions.

Antimicrobial Resistance is Linked to Poorer Pancreatic Outcomes

Antimicrobial resistance and Enterococcus infections were associated with delayed resolution, more interventions and poorer outcomes after pancreatic fluid collection therapy.

Person receives treatment in hospital

Radioactive Drug Shows Promise as Prostate Cancer Treatment

Lutetium-177 PSMA-617 cut the risk of prostate cancer progression or death by 28% when added to hormone therapy.